AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,758,000 | -23.5% | 168,399 | -21.3% | 0.38% | -31.9% |
| Q2 2022 | $2,299,000 | +13.3% | 214,033 | +143.5% | 0.56% | +69.0% |
| Q4 2020 | $2,029,000 | -53.3% | 87,882 | -71.7% | 0.33% | -51.7% |
| Q3 2015 | $4,342,000 | -40.4% | 310,394 | -39.7% | 0.69% | -19.2% |
| Q2 2015 | $7,280,000 | +6.9% | 514,470 | -17.8% | 0.85% | +8.4% |
| Q1 2015 | $6,808,000 | +3.6% | 625,694 | -20.8% | 0.79% | -14.3% |
| Q4 2014 | $6,571,000 | +80.4% | 789,840 | +29.0% | 0.92% | +23.9% |
| Q3 2014 | $3,643,000 | – | 612,199 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |